Chapter 4 Delirium
Delirium is by far the most common behavioral disorder in a medical-surgical setting. In general hospitals, the prevalence ranges from 11% to 33% on admission. The incidence ranges between 6% and 56% of hospitalized patients, 15% to 53% postoperatively in elderly patients, and 80% or more of intensive care unit (ICU) patients (Fong, Tulebaev, and Inouye, 2009; Michaud et al., 2007). The consequences of delirium are serious: They include prolonged hospitalizations, increased mortality, high rates of discharges to other institutions, severe impact on caregivers and spouses, and between $38 billion and $152 billion annually in direct healthcare costs in the United States (Breitbart, Gibson, and Tremblay, 2002; Fong, Tulebaev, and Inouye, 2009; Inouye et al., 1999).
Physicians have known about this disorder since antiquity. Hippocrates referred to it as phrenitis, the origin of our word frenzy. In the 1st century ad, Celsus introduced the term delirium, from the Latin for “out of furrow,” meaning derailment of the mind, and Galen observed that delirium was often due to physical diseases that affected the mind “sympathetically.” In the 19th century, Gowers recognized that these patients could be either lethargic or hyperactive. Bonhoeffer, in his classification of organic behavioral disorders, established that delirium is associated with clouding of consciousness. Finally, Engel and Romano (1959) described alpha slowing with delta and theta intrusions on electroencephalograms (EEGs) and correlated these changes with clinical severity. They noted that treating the medical cause resulted in reversal of both the clinical and EEG changes of delirium.
Despite this long history, physicians, nurses, and other clinicians often fail to diagnose delirium (Cole, 2004; Inouye et al., 2001), and up to two-thirds of delirium cases go unidentified (Inouye, 2004). Healthcare providers often miss this syndrome more from lack of recognition than misdiagnosis. The elderly in particular may have a “quieter,” more subtle presentation of delirium that may evade detection. Adding to the confusion about delirium are the many terms used to describe this disorder: acute confusional state, acute organic syndrome, acute brain failure, acute brain syndrome, acute cerebral insufficiency, exogenous psychosis, metabolic encephalopathy, organic psychosis, ICU psychosis, toxic encephalopathy, toxic psychosis, and others.
Clinical Characteristics
The essential elements of delirium are summarized in Boxes 4.1 and 4.2. Among the proposed American Psychiatric Association’s criteria (DSM-V Proposed Revision, 2013) for this disorder is a disturbance that develops over a short period of time; tends to fluctuate; and impairs awareness, attention, and other areas of cognition. In general, awareness, attention, and cognition fluctuate over the course of a day. Furthermore, delirious patients have disorganized thinking and an altered level of consciousness, perceptual disturbances, disturbance of the sleep/wake cycle, increased or decreased psychomotor activity, disorientation, and memory impairment. Other cognitive, behavioral, and emotional disturbances may also occur as part of the spectrum of delirium. Delirium can be summarized into the 10 clinical characteristics that follow.
Box 4.1 Clinical Characteristics of Delirium
Box 4.2
Diagnostic and Statistical Manual of Mental Disorders, Fifth edition, Proposed Revision, Criteria for Delirium due to a General Medical Condition
A. Disturbance in level of awareness and reduced ability to direct, focus, sustain, and shift attention
B. A change in cognition (such as deficits in orientation, executive ability, language, visuoperception, learning, and memory):
C. There is evidence from the history, physical examination, or laboratory findings that the disturbance is caused by the direct physiological consequences of a general medical condition
D. The disturbance develops over a short period of time (usually hours to a few days) and tends to fluctuate in severity during the course of a day
Modified from American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fifth ed., proposed revision. American Psychiatric Association, Washington, DC.
Cognitive and Related Abnormalities
Other Cognitive Deficits
Writing disturbance may be the most sensitive language abnormality in delirium. The most salient characteristics are abnormalities in the mechanics of writing: The formation of letters and words is indistinct, and words and sentences sprawl in different directions (Fig. 4.1). There is a reluctance to write, and there are motor impairments (e.g., tremors, micrographia) and spatial disorders (e.g., misalignment, leaving insufficient space for the writing sample). Sometimes the writing shows perseverations of loops or aspects of the writing. Spelling and syntax are also disturbed, with spelling errors particularly involving consonants, small grammatical words (prepositions and conjunctions), and the last letters of words. Writing is easily disrupted in these disorders, possibly because it depends on multiple components and is the least used language function.
Pathophysiology
Several brain areas involved in attention are particularly disturbed in delirium. Dysfunction of the anterior cingulate cortex is involved in disturbances of the management of attention (Reischies et al., 2005). Other areas include the bilateral or right prefrontal cortex in attentional maintenance and executive control, the temporoparietal junction region in disengaging and shifting attention, the thalamus in engaging attention, and the upper brainstem structures in moving the focus of attention. The thalamic nuclei are uniquely positioned to screen incoming sensory information, and small lesions in the thalamus may cause delirium. In addition, there is evidence that the right hemisphere is dominant for attention. Cortical blood flow studies suggest that right hemisphere cortical areas and their limbic connections are the “attentional gate” for sensory input through feedback to the reticular nucleus of the thalamus.
Another explanation for delirium is alterations in neurotransmitters, particularly a cholinergic-dopaminergic imbalance. There is extensive evidence for a cholinergic deficit in delirium (Inouye, 2006). Anticholinergic agents can induce the clinical and EEG changes of delirium, which are reversible with the administration of cholinergic medications such as physostigmine. The beneficial effects of donepezil, rivastigmine, and galantamine—acetylcholinesterase-inhibitor medications used for Alzheimer disease—may be partly due to an activating or attention-enhancing role. Moreover, cholinergic neurons project from the pons and the basal forebrain to the cortex and make cortical neurons more responsive to other inputs. A decrease in acetylcholine results in decreased perfusion in the frontal cortex. Hypoglycemia, hypoxia, and other metabolic changes may differentially affect acetylcholine-mediated functions. Other neurotransmitters may be involved in delirium, including dopamine, serotonin, norepinephrine, γ-aminobutyric acid, glutamine, opiates, and histamine. Dopamine has an inhibitory effect on the release of acetylcholine, hence the delirium-producing effects of l-dopa and other antiparkinsonism medications (Trzepacz and van der Mast, 2002). Opiates may induce the effects by increasing dopamine and glutamate activity. Recently, polymorphisms in genes coding for a dopamine transporter and two dopamine receptors have been associated with the development of delirium (van Munster et al., 2010).
Inflammatory cytokines such as interleukins, interferon, and tumor necrosis factor alpha (TNF-α), may contribute to delirium by altering blood-brain barrier permeability and further affecting neurotransmission (Cole, 2004; Fong et al., 2009; Inouye, 2006). The combination of inflammatory mediators and dysregulation of the limbic-hypothalamic-pituitary axis may lead to exacerbation or prolongation of delirium (Maclullich et al., 2008). Finally, secretion of melatonin, a hormone integral to circadian rhythm and the sleep/wake cycle, may be abnormal in delirious patients compared to those without delirium (van Munster, de Rooij, and Korevaar, 2009).
Diagnosis
Predisposing and Precipitating Factors
The greater the number of predisposing factors, the fewer or milder are the precipitating factors needed to result in delirium (Anderson, 2005) (Box 4.3). Four factors independently predispose to delirium: vision impairments (<20/70 binocular), severity of illness, cognitive impairment, and dehydration (high ratio of blood urea to creatinine) (Inouye, 2006). Among these, cognitive impairment or dementia is worth emphasizing. Elderly patients with dementia are five times more likely to develop delirium than those without dementia (Elie et al., 1998). Patients with dementia may develop delirium after minor medication changes or other relatively insignificant precipitating factors (Inouye, 2006